Fusidic acid non-antibacterial activity

International Journal of Antimicrobial Agents

Volumn 12, Issue SUPPL. 2, 1999, Pages

  Christiansen, Keryn ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Cytokines; Immunomodulatory effects; Insulin dependent diabetes mellitus; Tissue necrosis factor

Indexed keywords

CYTOKINE; FUSIDIC ACID; IMMUNOMODULATING AGENT; TUMOR NECROSIS FACTOR;

DRUG EFFECT; HUMAN; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK;

EID: 0032817184     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(98)00076-4     Document Type: Article

References (46)

1. Forsgren A, Banck G Influence of antibiotics on lymphocyte function in vitro. Infection. 6(Suppl. 1):1978;91-97.
2. Forsgren A, Schmeling D Effect of antibiotics on chemotaxis of human leukocytes. Antimicrob Agents Chemother. 11:1977;580-584.
3. Forsgren A, Schmeling D, Banck G Effect of antibiotics on chemotaxis of human polymorphonuclear leucocytes in vitro. Infection. 6(Suppl. 1):1978;102-106.
4. Bellahsene A, Forsgren A Effect of fusidic acid on the immune response in mice. Infect Immun. 29:1980;873-888.
5. Bendtzen K, Diamant M, Faber V Fusidic acid, an immunosuppressive drug with functions similar to cyclosporin A. Cytokine. 2:1990;423-429.
6. Chen YL, Le Vraux V, Giroud JP, Chauvelot-Moachon L Anti-tumor necrosis factor properties of non-peptide drugs in acute-phase responses. Eur J Pharmacol. 271:1994;319-327.
7. Nicoletti F, Zaccone P, Di Marco R et al. Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock. Immunology. 85:1995;645-650.
8. Genovese F, Mancuso G, Cuzzola M, Cusumano V, Nicoletti F, Bendtzen K, Teti G Antimicrob Agents Chemother. 40:1996;1733-1735.
9. Nicoletti F, Meroni PL, Lunetta M et al. Sodium fusidate and increased remission rate of insulin-dependent diabetes mellitus. Lancet. 337:1991;1292.
10. Bendtzen K, Diamant M, Horn T, Pedersen C, Buschard K Effect of fusidic acid on interleukin-1 (IL-1) and IL-6-induced pancreatic beta-cell functions in rats. J Endocrinol. 132:1992;345-352.
11. Buschard K, Pedersen C, Hansen SV, Hageman I, Aaen K, Bendtzen K Antidiabetogenic effect of fusidic acid in diabetes prone BB rats. Autoimmunity. 14:1992;101-104.
12. Nicoletti F, Di Marco R, Morrone S et al. Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid, Effect on T-cell proliferation and production of interferon-gamma. Immunology. 81:1994;317-321.
13. Burkart V, Bellmann K, Hartmann B, Heller B, Imai Y, Kolb H Fusidic acid suppresses nitric oxide toxicity in pancreatic islet cells. Biochem Pharmacol. 48:1994;1379-1385.
14. Faber V, Dalgleish AG, Newell A, Malkovsky M Inhibition of HIV replication in vitro by fusidic acid. Lancet. 2:1987;827-888.
15. Birch C, Tachedjian G, Gust I Diethanolamine fusidate has no in-vitro activity against the human immunodeficiency virus (letter). Med J Aust. 149:1988;224.
16. Richman DD, Mitsuya H, Broder S, Hostetler KY Fusidic acid, HIV, and host cell toxicity (letter). Lancet. 1:1988;1051-1052.
17. Lloyd G, Atkinson T, Sutton PM Effect of bile salts and of fusidic acid on HIV-1 infection of cultured cells. Lancet. 1:1988;1418-1421.
18. Czajkowski J, Tozzi V, Strannegard O Suppression of HIV replication in vitro by fusidic acid parallels cell toxicity (letter). J Antimicrob Chemother. 23:1989;155-156.
19. Maehlen T, Degre M Lack of activity of fusidic acid against human immunodeficiency virus in monocytes. Antimicrob Agents Chemother. 33:1989;680-683.
20. Novelli V, Ekteish F, Osundwa V Reversal of anergic state in human immunodeficiency virus infected thalassemic children treated with fusidic acid (letter). Pediatr Infect Dis J. 7:1988;821.
21. Youle MS, Hawkins DA, Lawrence AG, Tenant-Flowers M, Shanson DC, Gazzard BG Clinical, immunological, and virological effects of sodium fusidate in patients with AIDS or AIDS-related complex (ARC): An open study. J Acquir Immune Defic Synd. 2:1989;59-62.
22. Hording M, Christensen KC, Faber V Fusidic acid treatment of HIV infection: no significant effect in a pilot trial. Scand J Infect Dis. 22:1990;649-652.
23. Jorgensen AF, Mwakyusa D, Cegielski P et al. The effect of fusidic acid on Tanzanian patients with AIDS (letter). AIDS. 4:1990;1037-1038.
24. Famularo G, De Simone C, Tzantzoglou S, Trinchieri V, Moretti S, Tonietti G In vivo and in vitro efficacy of fusidic acid in HIV infection. Ann NY Acad Sci. 685:1993;341-343.
25. Degre M, Beck S Anti-HIV activity of dideoxynucleosides, foscarnet and fusidic acid is potentiated by human leukocyte interferon in blood-derived macrophages. Chemotherapy. 40:1994;201-208.
26. Smyth NR, McCracken C, Gaskell RM et al. Susceptibility in cell culture of feline immunodeficiency virus to eighteen antiviral agents. J Antimicrob Chemother. 34:1994;589-594.
27. Lazdins JK, Grell M, Walker MR, Woods-Cook K, Scheurich P, Pfizenmaier K Membrane tumour necrosis factor induced cooperative signalling of TNFR60 and TNFR80 favours induction of cell death rather than virus production in HIV infected cells. J Exp Med. 185:1997;81-90.
28. Rubisz-Brzezinska J, Zebracka T, Mozdzanowska K, Bendkowski W, Mozdzanowski J Treatment of systemic scleroderma with fucidin. Przegl Dermatol. 70:1983;209-215.
29. Rubisz-Brzezinska J, Zebracka T, Mozdzanowska K, Mozdzanowski J Treatment of systemic scleroderma with fucidine with regard to some free amino acids contents before and after therapy. Acta Derm-Venereol. 64:1984;267-270.
30. Rubisz-Brzezinska J, Zebracka T, Mozdzanowski J, Mozdzanowska K. Fucidin, a therapeutic trial in systemic sclerosis. Zeitschr Hauthranih. 59:1984;1611-1619.
31. Rubisz-Brzezinska J, Zebracka T, Mozdzanowska K, Mozdzanowski J Treatment of systemic scleroderma with fucidin in relation to clinical evaluation and analysis of free amino acids in the serum. Przegl Dermatol. 73:1986;305-311.
32. Langholz E, Brynskov J, Freund LG, Bendtzen K Fusidic acid for Behcet's colitis: a novel approach to T-cell specific immunosuppressive therapy. Dan Med Bull. 38:1991;284.
33. Langholz E, Brynskov J, Bendtzen K, Vilien M, Binder V Treatment of Crohn's disease with fusidic acid: an antibiotic with immunosuppressive properties similar to cyclosporin. Aliment Pharmacol Therapeut. 6:1992;495-502.
34. Langholz E. and the Danish Fucidin Study Group. A placebo-controlled double-blind randomised 12 week trial of Fucidin therapy in active Crohn's disease. American Gastroenterological Association, 1995 (meeting abstract).
35. Bendtzen K, Vesti-Nielsen N, Petersen J, Andersen V, Bendixen G Treatment of chronic endogenous uveitis with fusidic acid. Lancet. 337:1991;552-553.
36. Voetmann E Fusidic acid treatment in psoriasis. Lancet. 2:1971;435.
37. Jackson N Fusidic acid treatment in psoriasis. Lancet. 2:1971;712.
38. Kurwa A, Abdel-Aziz AH Preliminary clinical trial of fusidic acid in psoriasis. Br J Clin Pract. 27:1973;92-94.
39. Hall-Smith P Fusidic-acid treatment in psoriasis. Lancet. 2:1971;544.
40. Forstrom L, Lassus A Fucidic acid and psoriasis. Ann Clin Res. 6:1974;165-166.
41. Levantine AV, Baker H Fusidic acid treatment in psoriasis. Lancet. 2:1971;661.
42. Nyfors A Fucidin in psoriasis. A double-blind study of twenty psoriatics over two periods of 4 weeks each. Dermatologica. 146:1973;281-284.
43. Mackey JP Fusidic acid in psoriasis. (letter). Lancet. 2:1974;232.
44. Guarneri B, Fallica L Results with sodium fusidate in 30 cases of psoriasis. Gitaldermminerva-Derm. 109:1974;162-166.
45. Thornes RD, Sheehan MV Fucidin therapy in carcinoma of the breast. (Preliminary report). J Ir Med Assoc. 58:1966;52-54.
46. Cross F Topical sodium fusidate in senile keratosis. Lancet. 2:1971;878.